What the science is saying right now

The autism research field is making significant strides in understanding the condition's biological diversity, with groundbreaking studies identifying distinct subtypes through brain imaging and genetic analysis. These discoveries are beginning to explain the wide variation in autistic experiences and may lead to more personalized support approaches. At the same time, the field is confronting persistent disparities in diagnosis and care, particularly for women, older adults, and marginalized communities where camouflaging behaviors and systemic biases lead to underidentification. Technological advances like AI and eye-tracking offer promising tools for earlier detection and support, though researchers caution these must complement rather than replace human judgment. Meanwhile, debates continue about how to balance emerging biological insights with neurodiversity principles that prioritize autonomy and accommodations. The retraction of a major leucovorin trial has underscored the need for rigorous evidence in treatment approaches, even as community demand grows for solutions to co-occurring challenges like sleep disturbances and gastrointestinal issues. Across all these areas, a common thread is the increasing recognition that autistic voices must guide research priorities and interpretations to ensure findings translate into meaningful improvements in quality of life.